Latest news for Euroapi (OTC:EAPIF) Stock

Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.

Euroapi SA

Needham analyst Mike Cikos reiterates Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Buy and maintains $50 price target.

News

Price Target

Reiteration

Analyst Ratings

TENB

Needham Reiterates Buy on Tenable Holdings, Maintains $50 Price Target

Jones Trading analyst Jason Weaver maintains Alpine Income Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINE#NYSE">PINE</a>) with a Buy and maintains $22 price target.

PINE

Jones Trading Maintains Buy on Alpine Income Prop Trust, Maintains $22 Price Target

B of A Securities analyst John Murphy upgrades Mobileye Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) from Underperform to Neutral and raises the price target from $12 to $19.

Upgrades

MBLY

B of A Securities Upgrades Mobileye Global to Neutral, Raises Price Target to $19

Needham analyst Matt Dezort reiterates Qualys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLYS#NASDAQ">QLYS</a>) from Hold to Hold.

QLYS

Needham Reiterates Hold on Qualysto Hold

Edgewell Personal Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPC#NYSE">EPC</a>) just disclosed its Q1 earnings on Monday, February 10, 2025 at 06:00 AM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Edgewell Personal Care missed estimated earnings by -42.0%, reporting an EPS of $0.07 versus an estimate of $0.12.
Revenue was down $10.50 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company beat on EPS by $0.05 in the last quarter, resulting in a 1.0% drop share price change the following day.
Here's a look at Edgewell Personal Care's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.67</td>
<td>1.01</td>
<td>0.72</td>
<td>0.06</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.72</td>
<td>1.22</td>
<td>0.88</td>
<td>0.24</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>535.23M</td>
<td>651.28M</td>
<td>606.45M</td>
<td>481.35M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>517.60M</td>
<td>647.80M</td>
<td>599.40M</td>
<td>488.90M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Edgewell Personal Care management provided guidance for FY 2025, expecting earnings between $3.15 and $3.15 per share.
To track all earnings releases for Edgewell Personal Care <a href="https://www.benzinga.com/quote/EPC/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Edgewell Personal Care Earnings Report: Q1 Overview

The Q4 earnings report for CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) was released on Monday, February 10, 2025 at 06:00 AM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
CNA Financial beat estimated earnings by 3.0%, reporting an EPS of $1.25 versus an estimate of $1.21.
Revenue was up $182.00 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.01 in the previous quarter, leading to a 1.0% increase share price change the next day.
Here's a look at CNA Financial's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.07</td>
<td>1.23</td>
<td>1.39</td>
<td>1.10</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.08</td>
<td>1.19</td>
<td>1.30</td>
<td>1.33</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>2.57B</td>
<td>3.55B</td>
<td>3.00B</td>
<td>2.95B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>3.62B</td>
<td>3.52B</td>
<td>3.44B</td>
<td>3.51B</td>
</tr>
</tbody>
</table>

To track all earnings releases for CNA Financial <a href="https://www.benzinga.com/quote/CNA/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: CNA Financial Q4

Needham analyst Chris Pierce reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) from Hold to Hold.

TSLA

Needham Reiterates Hold on Teslato Hold

Needham analyst Scott Berg reiterates Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Buy and maintains $400 price target.

Needham Reiterates Buy on Salesforce, Maintains $400 Price Target

Shiseido Co Sees FY2025 Sales JPY 995,000

Guidance

SSDOY

Shiseido Co Sees FY2025 Sales JPY 995,000

OMRON (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OMRNY#OTC">OMRNY</a>) reported quarterly earnings of $0.35 per share. This is a 473.77 percent increase over earnings of $0.06 per share from the same period last year. The company reported $1.35 billion in sales this quarter. This is a 4.06 percent decrease over sales of $1.40 billion the same period last year.

OMRNY

OMRON Q3 EPS $0.35 Up From $0.06 YoY, Sales $1.35B Down From $1.40B YoY

CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) reported quarterly earnings of $1.25 per share which beat the analyst consensus estimate of $1.21 by 3.31 percent. This is a 6.02 percent decrease over earnings of $1.33 per share from the same period last year. The company reported quarterly sales of $3.69 billion which beat the analyst consensus estimate of $3.62 billion by 1.91 percent. This is a 5.19 percent increase over sales of $3.51 billion the same period last year.

Earnings Beats

CNA Financial Q4 Adj $1.25 Beats $1.21 Estimate, Sales $3.69B Beat $3.62B Estimate

Sun Country Airlines Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNCY#NASDAQ">SNCY</a>) ("Sun Country Airlines") today announced the commencement of a proposed secondary public offering of 6,346,105 shares of its common stock by an affiliate of certain investment funds managed by affiliates of Apollo Global Management, Inc. (the "Selling Stockholder"), which represent all the remaining shares owned by the Selling Stockholder.
Sun Country Airlines is not selling any shares and will not receive any proceeds from the proposed offering.
In addition, Sun Country Airlines has authorized the purchase from the underwriters of approximately $10 million of shares of common stock that are the subject of the proposed offering at a price per share equal to the price at which the underwriters will purchase the shares from the Selling Stockholder in the proposed offering, subject to a maximum aggregate repurchase price of $10 million (the "Concurrent Share Repurchase"). Sun Country Airlines plans to fund the Concurrent Share Repurchase from existing cash on hand.

Offerings

Buybacks

SNCY

Sun Country Airlines Announces $10M Stock Buyback Amid Stock Offload Of 6.34M Shares By Selling Stockholders By Apollo Global Management

Shiseido Co (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSDOY#OTC">SSDOY</a>) reported quarterly losses of $(0.17) per share. This is a 950 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $1.76 billion in sales this quarter. This is a 3.66 percent increase over sales of $1.70 billion the same period last year.

Shiseido Co Q4 EPS USD$(0.17) Down From USD$0.02 YoY, Sales USD$1.76B Up From USD$1.70B YoY

Nokia Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) revealed a change in leadership as its President and CEO, Pekka Lundmark, is set to step down from his role. His replacement, Justin Hotard, is set to assume the position of President and CEO on April 1, 2025.
Lundmark, who has guided the company since 2020, will officially <a target="_blank" href="https://www.nokia.com/about-us/news/releases/2025/02/10/inside-information-nokia-announces-a-leadership-transition-justin-hotard-appointed-as-successor-to-pekka-lundmark/" rel="noreferrer noopener">depart </a>on March 31, 2025. Lundmark will remain involved as an advisor to Hotard throughout the remainder of 2025.
Hotard has more than 25 years of experience in the global tech industry, including leadership roles at prominent companies such as Intel Corp, Hewlett Packard Enterprise Co, and NCR Corporation.
Currently, he heads Intel&#8217;s Data Center &amp; AI Group, driving innovation, technological leadership, and strategies focused on growth.
Hotard will be based at Nokia&#8217;s headquarters in Espoo, Finland.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43563232/software-company-solarwinds-to-go-private-in-44b-deal-stocks-skyrocket" rel="noreferrer noopener">Software Company SolarWinds Agrees To Go Private In $4.4B Deal</a>
The leadership change follows a period of significant transformation at Nokia under Lundmark&#8217;s guidance, as the company worked to solidify its standing in the tech sector.
&#8220;Pekka joined at a difficult time in Nokia&#8217;s history. Under his tenure, Nokia has re-established its technology leadership in 5G radio networks and built a strong position in cloud-native core networks. Network Infrastructure has delivered growth and significant profit improvement, and Nokia has secured the longevity of its patent licensing business,&#8221; said Chair of Nokia&#8217;s Board of Directors, Sari Baldauf.
&#8220;I am delighted to welcome Justin to Nokia. He has a strong track record of accelerating growth in technology companies along with vast expertise in AI and data center markets, which are critical areas for Nokia&#8217;s future growth.&#8221;
Last month, Nokia reported net sales growth of 10% year-on-year to 5.98 billion euros ($6.39 billion) in the fourth-quarter, beating the consensus estimate of $6.17 billion, indicating a rebound in demand from communication service providers, <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43336863/nokia-q4-earnings-beats-estimates-strong-growth-network-cloud-boosts-profitability" rel="noreferrer noopener">particularly in North America</a>.
Established in 1865, Nokia is a prominent player in the telecommunications and consumer electronics sectors, focusing on mobile networks, software, and tech solutions.
Price Action: NOK shares closed higher by 0.42% at $4.81 on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43566749/spire-global-lands-72m-contract-for-canadian-wildfire-detection-stock-jumps" target="_blank" rel="noreferrer noopener">Spire Global Lands ~$50M Contract For Canadian Wildfire Detection</a></li>
</ul>

Equities

Management

Tech

General

INTC

Nokia Taps Intel's AI Executive As New CEO - Details

ORIX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IX#NYSE">IX</a>) reported quarterly earnings of $2.56 per share which missed the analyst consensus estimate of $2.64 by 3.14 percent. This is a 3.87 percent decrease over earnings of $2.66 per share from the same period last year. The company reported $4.930 billion in sales this quarter. This is a 7.41 percent increase over sales of $4.590 billion the same period last year.

Earnings Misses

ORIX Q3 2024 GAAP EPS $2.56 Misses $2.64 Estimate, Sales $4.930B Up From $4.590B YoY

FreeCast and Foxx Development are announcing a new distribution agreement, bringing FreeCast's free streaming app to hundreds of thousands of smartphones and tablets. The FreeCast app is a one-stop source for live and on-demand video content, integrating hundreds of streaming apps into one easy-to-use platform. With FreeCast, consumers can find all the content they want to watch across different sources and providers for the lowest possible price.
Foxx Development is a consumer electronics and integrated Internet-of-Things (IoT) solution company. With robust research and development capabilities, it currently sells a diverse range of products including mobile phones, tablets and other consumer electronics devices throughout the United States. Foxx Development is a device provider for the National Lifeline Program, a federally funded program providing smartphones and wireless service to low-income consumers, with which FreeCast has extensive experience.

FCST

FOXX

FreeCast Teams Up With Foxx Development to Expand Free Streaming Access on Smartphones and Tablets

Shares of BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) rose sharply in pre-<a href="https://www.benzinga.com/quote/BP">market trading.</a>
The Wall Street Journal reported Sunday that Elliott Management has built a stake in BP and will push for transformational changes.
BP shares jumped 6% to $34.20 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Patriot National Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNBK#NASDAQ">PNBK</a>) gained 70.6% to $2.44 in pre-market trading after falling over 3% on Friday.</li>
<li>Starbox Group Holdings Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) rose 51% to $0.5020 in pre-market trading after falling around 4% on Friday.</li>
<li>MGO Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) gained 43.3% to $0.5953 in pre-market trading after jumping 124% on Friday.</li>
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) gained 32.1% to $0.0795 in pre-market trading after dipping over 28% on Friday.</li>
<li>Yoshiharu Global Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YOSH#NASDAQ">YOSH</a>) shares jumped 24.4% to $8.20 in pre-market trading after jumping 34% on Friday.</li>
<li>Microbot Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBOT#NASDAQ">MBOT</a>) gained 20% to $3.06 after surging around 18% on Friday.</li>
<li>Solid Biosciences Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) shares climbed 19.1% to $3.43 in pre-market trading after dipping 8% on Friday.</li>
<li>Satellogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) gained 13.6% to $4.19 in pre-market trading after climbing 10% on Friday.</li>
<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) gained 9.4% to $20.44 in pre-market.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Fennec Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FENC#NASDAQ">FENC</a>) shares fell 54.8% to $3.00 in pre-market trading.</li>
<li>Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) dipped 54.5% to $3.54 in pre-market trading after the company issued an update on BEACON-IPF, a Phase 2b/3 trial in patients with idiopathic pulmonary fibrosis.</li>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) fell 32.7% to $0.2550 in today's pre-market trading after gaining over 11% on Friday.</li>
<li>PS International Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSIG#NASDAQ">PSIG</a>) shares fell 25.4% to $0.4701 in pre-market trading after gaining 5% on Friday.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) shares tumbled 25.2% to $40.75 in pre-market trading. Semtech shares fell around 10% on Friday after Baird cut its price target on the stock from $80 to $60.</li>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) declined 20.2% to $0.91 in pre-market trading after falling more than 5% on Friday.</li>
<li>Replimune Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) fell 19.6% to $11.21 in pre-market trading. Replimune announced inducement grants under Nasdaq Listing Rule 5635(c)(4).</li>
<li>Maze Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) fell 9.5% to $12.11 in pre-market trading. Maze Therapeutics shares gained around 3% on Friday after the company announced that the first patient has been dosed in the company&#8217;s Phase 2 clinical trial, the HORIZON Study, of MZE829 in patients with APOL1 kidney disease.</li>
<li>Dogness (International) Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) fell 6.6% to $33.00 in pre-market trading.</li>
<li>The Manitowoc Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTW#NYSE">MTW</a>) shares dipped 6.4% to $9.12 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a></li>
</ul>

CENX

DOGZ

FENC

MAZE

MBOT

MGOL

MYNA

ORIS

PLRX

PNBK

PSIG

REPL

SATL

SLDB

SMTC

STBX

YOSH

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

U.S. GoldMining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USGO#NASDAQ">USGO</a>) ("U.S. GoldMining"&nbsp;or the "Company") is&nbsp;pleased to announce new assay results from the 2024 confirmatory diamond core drilling program completed at the Whistler Gold-Copper Project (the "Project") in Alaska, U.S.A.
The results reported in this news release highlight WH24-05, which was drilled adjacent to the Raintree West Deposit (the "Raintree Deposit"). The drilling intercepted multiple zones of high-grade gold and silver polymetallic mineralization approximately 500 meters south of any prior drilling at the deposit.
Selected Highlights:
<ul>
<li>Main Zone composite intercept of 138.0&nbsp;meters (m) at&nbsp;0.99 grams per tonne (g/t) gold equivalent (AuEq)&#x2A;&nbsp;comprising 0.89&nbsp;g/t gold (Au) and 0.05 percent (%) copper (Cu), plus 17.57 g/t silver (Ag), 0.44% lead (Pb) and 0.95% zinc (Zn) (elevated Ag, Pb and Zn grades are excluded in the AuEq calculations), from 635.0 m to 773.0 m down hole.</li>
<li>Including higher-grade individual intercepts:
<ul>
<li>26 m at 1.48 g/t AuEq&nbsp;(1.36 g/t Au, 0.06% Cu) plus 15.38 g/t Ag, 0.69% Pb and 1.61% Zn</li>
<li>34 m at 1.65 g/t AuEq&nbsp;(1.49 g/t Au, 0.08% Cu) plus 19.95 g/t Ag, 0.81% Pb and 1.35% Zn</li>
<li>18 m at 1.93 g/t AuEq&nbsp;(1.70 g/t Au, 0.13% Cu) plus 66.33 g/t Ag, 0.62% Pb and 1.84% Zn</li>
</ul>
</li>
<li>The drill intercept represents a relatively new style of&nbsp;mineralization - high-grade gold and silver polymetallic veins - with only one other intercept previously drilled at the Raintree Deposit:</li>
<li>This new discovery validates the Company's exploration strategy of exploring the Project to maximize its resource potential. Additional follow-up drilling is planned this coming summer.</li>
</ul>

USGO

US GoldMining Uncovers High-Grade Gold and Silver at Whistler Project in Alaska

Edgewell Personal Care Sees FY25 Adj EPS Of $3.15 - $3.35 Vs. $3.18 Est.

It &nbsp;is payable&nbsp;March&nbsp;13, 2025 to stockholders of record on February&nbsp;24, 2025.

Comments

Euroapi

News

Latest news for Euroapi (OTC:EAPIF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga